Kerydin

Active Ingredient(s): Tavaborole
FDA Approved: * July 7, 2014
Pharm Company: * ANACOR PHARMS INC
Category: Antifungal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Kerydin Overview

Tavaborole (trade name Kerydin) is a topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed. Tavaborole began its Phase 3 trials in December 2010[1] and was approved by the US FDA in July 2014.[2] Tavaborole inhibits an essential fungal enzyme, leucyl-tRNA synthetase, that is required for protein synthesis. The inhibition of protein synthesis leads to termination of cell growth and then cell death, elimin...

Read more Kerydin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tavaborole

Recent Kerydin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tavaborole
  • Solution: 5%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Kerydin: (2 results)

Sorted by National Drug Code
  • 10337-905 Kerydin 43.5 mg/ml Topical Solution by Pharmaderm, a Division of Fougera Pharmaceuticals Inc.
  • 55724-111 Kerydin 43.5 mg/ml Topical Solution by Anacor Pharmaceuticals, Inc

Other drugs which contain Tavaborole or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 25 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA